Cordlife Group Limited (SGX:P8A)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.2450
0.00 (0.00%)
At close: Jul 18, 2025, 5:00 PM SGT

Cordlife Group Company Description

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally.

It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples.

The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test services.

The company also provides corneal lenticule banking, gut microbiome banking, and lifestyle genetic screening services for adults.

In addition, it offers Moms Up, a mobile application that offers parenting resources, as well as sprouts for health, wellness, and lifestyle needs.

Further, the company provides medical laboratory, marketing, and property investment services, as well as medical and pharmaceutical research and development and consulting services.

Cordlife Group Limited was incorporated in 2001 and is based in Singapore.

Cordlife Group Limited
CountrySingapore
Founded2001
IndustryMiscellaneous Health And Allied Services, Not Elsewhere Classified
Employees538
CEOXiaoling Chen

Contact Details

Address:
1 Kim Seng Promenade
Singapore, 237994
Singapore
Phone65 6238 0808
Websitecordlife.com

Stock Details

Ticker SymbolP8A
ExchangeSingapore Exchange
Fiscal YearJanuary - December
Reporting CurrencySGD
SIC Code8090

Key Executives

NamePosition
Xiaoling ChenChief Executive Officer
Hnin Yi ThetChief Financial Officer